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ABSTRACT
Lossofafunctionalmismatchrepair(MMR)systemin
colorectal cancer (CRC) cells is associated with
microsatellite instability and increased sensitivity
to topoisomerase inhibitors. In this study, we have
investigated whether a defect in double-strand break
(DSB) repair by non-homologous end-joining (NHEJ)
couldexplainwhyMMR-deficientCRCcellsarehyper-
sensitive to camptothecin (CPT), a topoisomerase I
inhibitor. To evaluate the efficiency and the fidelity
of DSB repair, we have transiently transfected plas-
mids containing cohesive or non-complementary
ends in cells with various MMR defects. We have
observedthattherepairefficiencyofDSBwithcohes-
iveand non-complementaryends iscomparable inall
cell lines. In contrast to the MMR-proficient cell line
HT29, the MMR-deficient cell lines were highly accur-
ateinrepairingDSBwithcohesiveends,butthischar-
acteristiccouldnotbedirectlyassignedtotheprimary
MMR deficiency. Furthermore, CPT treatment had
no detectable effect on the repair of cohesive ends
but significantly decreased the repair efficiency of
non-complementary DSB. In conclusion, although
our observations show that DSB repair efficiency
by NHEJ decreases upon treatment with CPT, which
possibly contributes to its cytotoxicity, it is quite
unlikely that it accounts for the hypersensitivity of
MMR-deficient cells to topoisomerase inhibitors.
INTRODUCTION
In a previous study, we have found that loss of a functional
mismatch repair system (MMR) in colorectal cancer (CRC)
cell lines is associated with hypersensitivity to camptothecin
(CPT), a topoisomerase I inhibitor, and etoposide, a topoi-
somerase II inhibitor (1). Germ-line mutations in MMR
genes, predominantly hMSH2 and hMLH1, have been identi-
ﬁed in 50–70% of patients with hereditary nonpolyposis color-
ectal cancer (HNPCC) [reviewed in (2,3)]. HNPCC-associated
tumors are characterized by high instability in simple repet-
itive microsatellite sequences. This characteristic phenotype,
referred as microsatellite instability (MSI), is also observed in
10–15% sporadic CRC (4,5). Because we have further shown
that patients with MSI-CRC are more prone to beneﬁt from
chemotherapy with irinotecan, a CPT derivative, we were
interested in determining the molecular mechanisms respons-
ibleforthe increasedsensitivityof MSItumors tothisdrug (6).
CPT and etoposide both interfere with the catalytic cycle of
topoisomerases by stabilizing the covalent complex formed by
topoisomerase and cleaved DNA, called cleavage complex
(7,8). By increasing the half-life of the cleavage complexes
formed by topoisomerase II and DNA, etoposide generates
higher levels of double-strand breaks (DSBs). The toxicity
of CPT is primarily due to the conversion of single-strand
break to DSB during S-phase when the replication fork col-
lides with the cleavage complexes formed by topoisomerase
I–DNA and CPT (9). Thus far, little is known about the mech-
anisms that can remove the cleavage complexes and repair the
breaks induced by topoisomerase inhibitors. Yet, the breakage
ends produced by topoisomerase inhibitors or ionizing radi-
ation are not directly ligatable and need processing prior to
end-joining. Several authors have proposed that homologous
recombination, as well as non-homologous end-joining
(NHEJ) could participate in the repair of the breaks generated
at the sites of DNA lesions induced by topoisomerase inhibi-
tors [reviewed in (9)]. In mammalian cells, DSBs are predom-
inantly repaired by NHEJ, a pathway that relies on DNA–PK,
a complex formed by the Ku70/Ku80 heterodimer and a
catalytic subunit, DNA–PKcs, a member of the phosphatidyl-
inositol 3-kinase family. The complex Ku is able to bind free
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to recruit DNA–PKcs; subsequently ligase IV and its cofactor,
XRCC4, are recruited to perform ligation (10). Several obser-
vations have recently emphasized that hypersensitivity to
topoisomerase inhibitors may be related to a defect in DSB
repair by NHEJ. Mutants for Ku80 or Ku70 are hypersensitive
to etoposide, while a defect in DNA–PKcs sensitizes to CPT
(11–13).
In addition to repairing base–base mispairs, as well as small
insertion or deletion loops arising during DNA replication,
some MMR components, including hMSH2, hMSH6 and
hMLH1, participate in recombination, DSB repair, apoptosis
and cell cycle regulation (14–16). Thus, we undertook this
study to deﬁne whether DSB repair by NHEJ is impaired in
MMR-deﬁcient CRC cell lines. In order to evaluate the efﬁ-
ciency and the accuracy of DSB repair, we have transiently
transfecteda plasmid linerarized with restrictionenzymes gen-
eratingcohesiveendsornon-complementaryendsinapanelof
CRC cell lines with various defects in MMR. Our results show
that (i) the DSB repair efﬁciency of either cohesive or non-
cohesive ends is not affected by a defect in MMR, (ii) the
accuracy of end-joining is signiﬁcantly higher in MMR-
deﬁcient cell lines, a characteristic that nevertheless persists
in MMR-complemented cell lines and (iii) treatment with
CPT signiﬁcantly decreases the repair efﬁciency of DSB with
non-cohesive ends in all cell lines. In conclusion, our observa-
tions rule out the possibility that the hypersensitivity of
MMR-deﬁcient CRC cell lines to topoisomerase inhibitors
occurs as a consequence of defective DSB repair by NHEJ.
MATERIALS AND METHODS
Cell lines
We have used six different cell lines that are proﬁcient or not
for MMR: HT29 (MMR+), LoVo (hMSH2 ), HCT116
(hMLH1 ), mlh1-2 (hMLH1-complemented HCT116), DLD1
(hMSH6 ) and DLD1-ch2 (hMSH6-complemented DLD1)
(see Supplementary Material). With the exception of LoVo,
all cell lines were grown in monolayer cultures in DMEM
supplemented with penicillin (100 mg/ml), streptomycin
(100 U/ml), L-glutamine (2 mM) and 10% heat-inactivated
fetalcalfserum(FCS).LoVowasgrowninmonolayercultures
in a mixture composed of DMEM and Ham’s F-12 (v/v) sup-
plemented as for DMEM. The mlh1-2 cell line obtained by
transfecting the hMLH1-deﬁcient HCT116 cell line with a
wild-type hMLH1-expression vector was continuously
grown in the presence of hygromycin (100 mg/ml) (1). The
DLD1-ch2, a kind gift from Thomas Kunkel, obtained by
introducing the entire chromosome 2 tagged with the neo-
mycin resistance gene, was grown in the presence of G418
(600 mg/ml) (17).
Plasmid preparation
The pHRecSJ plasmid used in the in vivo cell end-joining
assay contains the prokaryotic ColEI origin and the
b-lactamase gene (AmpR), and was kindly given by Dora
Papadopoulo (18). The plasmid was linearized with restriction
enzymes that recognize a unique site within the substrate:
EcoRI [50-protruding single stranded (PSS) cohesive ends],
ApaI (30-PSS cohesive ends) or both enzymes together
(non-complementary ends) (New England Biolabs). The
completeness of the digestion was assessed by transforming
linearized substrates into XL1-blue Escherichia coli, and was
shown to be >99%. The pEGFP-C1 (Clontech) plasmid con-
taining a bacterial replication origin and the gene that confers
the resistance to kanamycin was used as a control to monitor
the transfection and transformation efﬁciencies.
Transient transfection and plasmid recovery
All cell lines were transfected by electroporation using an
Easyject apparatus (Eurogentec). Exponentially growing
cells (3 · 10
6) were resuspended in culture medium without
FCS, supplemented with 20 mM HEPES and electroporated
with various amounts of circular (15–500 ng) or linearized
(500 ng) pHRecSJ plasmids together with circular pEGFP-C1
(500 ng). The conditions of electroporation were either simple
pulse at: 250 V and 1500 mF for HT29; 260 V and 1500 mF for
LoVo;230Vand1500mFforDLD1andDLD1-ch2;ordouble
pulse for HCT116 and mlh1-2, with the ﬁrst pulse at 1000 V
and 25 mF and the second pulse 1 ms later at 100 V and
2500 mF. Forty-eight hours after transfection, plasmids were
recovered by a rapid alkaline extraction procedure (19).
Efficiency of DSB repair
Following extraction, lysates were electro-transformed into
XL1-blue competent bacteria and plated on Luria–Bertani
(LB) plates containing ampicillin (50 mg/ml) or kanamycin
(25 mg/ml). The number of bacterial colonies obtained on
kanamycin plates was used to normalize the different steps
from transfection to plasmid recovery and bacterial trans-
formation. Thenumberofbacterial coloniesobtainedonampi-
cillin plates with the different amounts of circular plasmids
served to establish a standard curve. The number of bacterial
colonies on ampicillin plates obtained with lysates of cells
transfected with linearized plasmids allowed us to determine
the quantity of plasmids that have been recircularized, using
the standard curve. The efﬁciency of repair was calculated by
dividing the quantity of plasmid recircularized versus the
quantity of plasmid transfected. The mean percentages of
repair efﬁciency were determined from a minimum of three
independent experiments, as indicated in Figures 1 and 4.
Fidelity of DSB repair events
The ratio of error-free and error-prone repair events was deter-
mined by screening for the regeneration of the original restric-
tion site. Bacterial colonies were subcultured from ampicillin
plates and grown in suspension in 100 ml of LB containing
ampicillin (50 mg/ml) at 37 C. After 6 h, 1 ml was used to
perform a PCR, using the sense primer: 50-GCGCGTCCC-
ATTCGCCATTCAGGC-30 and the antisense primer: 50-
CGCCACCTCTGACTTGAGCGTCGA-30 (corresponding to
positions 434–457 and 1565–1588, respectively). PCR was
performed in a total volume of 20 ml using 200 mM dNTP
(Amersham Pharmacia Biotech, Piscataway) and 0.5 U of
rTaq DNA polymerase (Amersham Pharmacia Biotech).
After an initial 10 min denaturation step at 95 C, ampliﬁcation
was achieved by performing 35 cycles consisting of 1 min
denaturation at 95 C, 1 min annealing at 68 C and 2 min
elongation at 72 C, followed by a 10 min ﬁnal elongation
step at 72 C.
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previously used to linearize the plasmids. Brieﬂy, digestion
was carried out in a ﬁnal volume of 40 ml by adding to the
entire PCR product 1 U of EcoRI (position 978) or 1 U of ApaI
(position 988). After 3 h of incubation at 37 C for EcoRI or
25 C for ApaI, the digestion products were migrated in a 1%
agarose gel. The PCR products obtained from accurately
repaired plasmids can be recut by the enzyme, giving rise
to two bands that can be visualized on the gel, while error-
prone repair events cannot be cleaved giving a unique band
whose size permits to estimate the size of the deletion. The
accuracy of the repair events and the approximate size of the
various deletions were determined by analyzing the restriction
proﬁle. The deletion sizes were distributed in three groups:
small (<50 bp), intermediate (50–500 bp) and large (>500 bp);
the assignment accuracy was checked by sequencing 200
error-prone repair events. The mean frequency of accurately
repaired DSB was established by analyzing at least three
independent experiments per cell line with a minimum of
250 bacterial colonies for each cell type and DSB type.
CPT treatment
A 25 mM stock solution of CPT (Sigma, St Louis) was pre-
pared in dimethyl sulfoxide, aliquoted and kept at  20 C until
used. After electroporation with the plasmids, the cells were
resuspended in complete medium supplemented with 20 mM
HEPES and with CPT at a ﬁnal concentration of 100 nM.
Detection of frameshift mutations in mononucleotide
repeats
Frameshift mutations located in the mononucleotide repeated
sequences of BRCA1 (poly-A8), BRCA2 (poly-A8), ATR
(poly-A10), DNA–PKcs (poly-A10), BLM (poly-A9), MRE11
(poly-T11) and RAD50 (poly-A9) were detected on PCR prod-
ucts performed on  50 ng genomic DNA using HotStarTaq
DNA Polymerase (Qiagen, Germany) and the following
oligonucleotides: 6-FAM-labeled-50-AGCCCACCTAATTG-
TACTG-30 and 50-CCATGAGTTGTAGGTTTCTG-30 for
BRCA1; 6-FAM-labeled-50-TTGCTCACAGAAGGAGGA-
CT-30 and 50-GCATTTGCTTCAAACTGGGCT-30 for
BRCA2; HEX-labeled-50-TCTTCTGTAGGAACTTGAAA-
GCC-30 and 50-TGAAAGCAAGTTTTACTGGACTAGG-30
for ATR; HEX-labeld-50-GAAGTTCTAGACTCATGGATG-
30 and 50-GTGCATCTCACCTGTATCTGG-30 for DNA–
PKcs; 6-FAM-labeled-50-CTCTGCCACCAGGAAGAATC-
30 and 50-ACAGCAGTGCTTGTGAGAAC-30 for BLM;
HEX-labeled-50-AATATTTTGGAGGAGAATCTTAGGG-30
and 50-AATTGAAATGTTGAGGTTGCC-30 for MRE11;
and NED-labeled-50-AACTGCGACTTGCTCCAGAT-30 and
50-CAAGTCCCAGCATTTCATCA-30 for RAD50. Ampli-
ﬁcation consisted in a 15 min step at 95 C, followed by
50 cycles of 30 s at 96 C, 30 s at 55 C, 30 s at 72 C and
a ﬁnal extension step of 5 min at 72 C. Adequate dilutions of
the ﬂuorescent PCR products were mixed with formamide
and GS-HD400-ROX molecular weight standards, heat-
denaturated and run on a short capillary containing GS Per-
formance Optimized Polymer 4, at a voltage of 15 kV on the
ABI 310 Genetic Analyzer using the GeneScan 3.2 software
(Applied Biosystems).
RESULTS
Rejoining efficiency through NHEJ in MMR-deficient
and MMR-proficient cell lines
Using an in vivo plasmid-based assay, we have determined the
ability of the various cell lines to repair DSB with cohesive
30-PSS or 50-PSS ends, or with non-complementary ends.
Histograms shown in Figure 1 represent the mean percentages
of the repair efﬁciency established from a minimum of
three independent experiments. As shown in Figure 1, we have
observed signiﬁcant differences in the repair efﬁciency within
the cell lines tested, for 30-PSS (P < 0.001), 50-PSS (P = 0.001)
Figure1.End-joiningefficiencyofDSBrepairbyNHEJinMMR-deficientandMMR-proficientCRCcelllines.Histogramsrepresentthemeanpercentageofrepair
efficiency established from a minimum of three independent experiments using plasmids linearized with ApaI (A), EcoRI (B) and ApaI-EcoRI (C). The number of
independent experiments is shown above each histogram. The P values refer to the comparison of all cell lines.
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Figure 1A, the repair efﬁciency of ApaI-induced 30-PSS
DSB was the highest in HCT116 (20.2%) and the lowest in
LoVo (10.5%) (P < 0.001). The average repair efﬁciency of 30-
PSS for all the cell lines tested was 15 – 3.3%. The lowest
repair efﬁciency of the EcoRI-linearized plasmid was again
observed for LoVo while mlh1-2, the hMLH1-complemented
HCT116, was the most efﬁcient cell line (7.5 versus 18.3%,
P=0.002),with anaveragerepairefﬁciencyof12.6–4.1%for
all cell lines (Figure 1B). As shown in Figure 1C, LoVo again
displayed the lowest efﬁciency of repair of plasmids with non-
complementary ends and HCT116 the highest level (13.3 ver-
sus 21%, P = 0.001), with an average efﬁcacy of 17.4 – 3%.
Whatever substrates tested, there were no signiﬁcant differ-
ences in the efﬁciency of repair between HCT116 and mlh1-2,
its hMLH1-complemented cell line (P = 0.31 for 30-PSS,
P = 0.08 for 50-PSS and P = 0.37 for non-complementary
ends). Similarly, there were no signiﬁcant differences between
DLD1 and DLD1-ch2, its hMSH6-corrected derived cell line,
in which end-joining efﬁciencies were 16.0 versus 12.7% for
30-PSS (P = 0.22), 11.7 versus 16% for 50-PSS (P = 0.07) and
19.3 versus 14.3% for non-cohesive ends (P = 0.05). Alto-
gether, these results rule out the hypothesis of a direct link
between the efﬁciency of DSB repair and the primary defect in
MMR. This is further reinforced by the fact that HT29 (MMR-
proﬁcient) and LoVo (hMSH2-deﬁcient) are the two cell lines
that showed the lowest levels of repair of DSB with either
50-o r3 0-PSS. Comparing the repair efﬁciency of ApaI- and
EcoRI-induced DSB indicated that, with the exception of
HCT116, no cell line displayed signiﬁcant differences in
their ability to repair 50-PSS and 3-PSS DSB. Nevertheless,
with the exception of DLD1-ch2, the 50-PSS DSBs were
slightly less efﬁciently repaired, and the substrates with
non-complementary ends were the most efﬁciently rejoined.
Thus, these observations exclude the possibility that a defect
in MMR directly affects the ability of cells to repair DSB
with either 50-PSS or 30-PSS cohesive ends or with non-
complementary ends.
Rejoining fidelity through NHEJ in MMR-deficient
and MMR-proficient cell lines
Histograms shown in Figure 2represent the mean frequencyof
the error-free events obtained after repair of the various DSBs.
Interestingly, we have observed a strong difference in the end-
joining ﬁdelity of complementary ends between the MMR-
proﬁcient HT29 cell line and all other cell lines that were very
accurate in repairing both 30-PSS and 50-PSS cohesive ends
(P < 0.001 for both ApaI- and EcoRI-linearized plasmids)
(Figure 2A and B). Yet, in HT29, the end-joining accuracy
was 52.2 and 48% for ApaI- and EcoRI-linearized plasmids,
respectively, which is much lower than in HCT116 where
error-free repair was performed in 84 and 94.3% of events
(P < 0.001) (Figure 2A and B). For 30-PSS, HT29 showed the
lowest end-joining ﬁdelity and mlh1-2 the highest, with 52.2
versus 93.3% error-free events (P < 0.001). Whereas HCT116
showed a repair accuracy of 84% that is statistically different
when compared with mlh1-2, its complemented counterpart
(P = 0.04), we did not observe statistically signiﬁcant differ-
ences between DLD1 and DLD1-ch2, with 71.3 versus 72.7%
error-free events (P = 0.64). For 50-PSS, HT29 again showed
the lowest accuracy of repair with 48% and HCT116 the high-
est with 94.3%, a statistically signiﬁcant difference (P = 0.02).
As for 30-PSS, there was a statistically signiﬁcant difference
betweenHCT116 and mlh1-2 (94.3 versus 88%, P= 0.01), and
no signiﬁcant differences between DLD1 and DLD1-ch2
(P = 0.80). Thus, in our experiments, the repair accuracy
of DSB with complementary ends is similar for 30- and
Figure 2. End-joining fidelity of DSB repair by NHEJ in MMR-deficient and MMR-proficient CRC cell lines. Histograms represent the mean frequency in
percentage of the error-free events after repair of DSB induced by ApaI (A) or EcoRI (B) established from a minimum of three independent experiments and a
minimum of 250 bacterial colonies analyzed. The numbers of bacterial colonies analyzed are specified above the histograms for each CRC cell lines tested. The
P values refer to the comparison of all cell lines.
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MMR-proﬁcient HT29 cell lines and the other cell lines tested.
Furthermore, deletions associated with NHEJ events in HT29
were strikingly larger than in any of the MMR-deﬁcient cell
lines (P < 0.0001) (Figure 3). In HT29, deletions >500 bp
represented 48% of the events, while their frequency varied
from 16% for LoVo and HCT116 to 25% for DLD1 (Figure 3).
The repair events displaying small deletions represented <40%
in HT29, 60% in HCT116 and DLD1 and reached 76% in
LoVo (Figure 3). Thus, in the MMR-deﬁcient cell lines, the
repair process is less often error-prone than in HT29, and
involves smaller deletions.
Effects of CPT treatment on DSB repair in CRC
In order to test whether CPT affects DSB repair, we have
performed the same experiments in cells treated with CPT.
Histograms shown in Figure 3 represent the mean percentages
of repair efﬁciency established from a minimum of three
independent experiments. As shown in Figure 4A, the CPT-
induced decrease in repair efﬁciency of ApaI-induced DSB
was mild for HCT116 (20.2 versus 18.5%, P = 0.3) and for
LoVo (10.2 versus 6.2%, P = 0.16), but signiﬁcant for HT29
(12.4–5.7%, P < 0.001). CPT treatment did not induce any
drastic effects on the repair efﬁciency of EcoRI-induced DSB,
whatever cell lines tested (Figure 4B). Conversely, CPT treat-
ment led to a signiﬁcant decrease in the repair efﬁciency of
plasmids with non-complementary ends for all cell lines
(Figure 4C). Upon CPT treatment, the repair efﬁciency of
non-complementary ends in HT29 decreased from 17.3% in
untreated cells to 7.5% in cells treated with CPT (P = 0.04); it
decreased by 8.7% in HCT116 cells (21 versus 12.3%,
P < 0.001) and by 8% in LoVo cells (13.3 versus 5.3%,
P = 0.006) in CPT-treated cells. In conclusion, while CPT
treatment had no drastic effects on the repair efﬁciency of
DSB with cohesive ends, treatment with this drug signiﬁcantly
impaired the ability of cells to repair DSB with non-
complementary ends.
We have further determined the effects of CPT on the
accuracy of repair (see Supplementary Material). With the
exception of EcoRI-50-PSS repair in HT29, where CPT treat-
ment signiﬁcantly increased the repair accuracy (48 versus
67.8%, P = 0.007), CPT did not modify the end-joining ﬁdelity
whatever cell lines and substrates tested. Thus, CPT treatment
Figure 4. EffectofCPTtreatmentonDSBrepairefficiencyinCRCcelllines.Cellsweretreatedwith100nMCPTjustaftertransfectionanduntilplasmidrecovery.
HistogramsrepresentthemeanpercentageofrepairefficiencyestablishedfromaminimumofthreeindependentexperimentsforplasmidslinearizedwithApaI(A),
EcoRI(B)andApaI-EcoRI(C).ThenumbersofindependentexperimentsaremarkedaboveeachhistogramforeachCRCcelllinetested.OnlyPvaluesstatistically
different are specified.
Figure 3. Sizes of the deletions occurring during DSB repair by NHEJ of
plasmids with cohesive ends. Shown are the percentages of events with
small (<50 bp), intermediate (50–500 bp) or large (>500 bp) deletions, deter-
mined after migration on a 1% agarose gel. n represents the number of events
scoredforeachcellline.ThedifferencesbetweenHT29andtheMMR-deficient
celllineswerecomparedusingtheChi2test(P<0.0001forallthreecelllines).
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including HCT116, LoVo or DLD1 cell lines.
Detection and analysis of frameshift mutations in
DNA damage signaling and repair genes
In this study, we have observed signiﬁcant differences in the
repair ﬁdelity of DSB with cohesive ends among cell lines,
with the MMR-proﬁcient HT29 cell line being the least
accurate. Because neither the complementation of the hMLH1
defect in HCT116 nor the introduction of chromosome 2 in
DLD1 affected the repair accuracy of substrates with cohesive
ends, we concluded that the observed differences in end-
joining ﬁdelity could not be assigned to a direct inﬂuence
of MMR. Thus, we have searched for frameshift mutations
in mononucleotide repeats located within genes involved in
DNA repair, DNA damage signaling and in the response of
CPT treatment. In particular, we have studied the following
coding repeats: BRCA1 (A8), BRCA2 (A8), ATR (A10), DNA–
PKcs (A10), BLM (A9) and RAD50 (A9) genes. We have
performed the same analysis for the MRE11 gene that carries
an intronic T11 repeat whose mutation leads to aberrant spli-
cing and synthesis of a truncated protein. As expected, no
frameshift mutations in any of the genes could be detected
in the MMR-proﬁcient HT29 cell line (Table 1). None of the
MMR-deﬁcient cell lines displayed a mutation in BRCA1,
BRCA2, ATR or DNA–PKcs. Mutations in MRE11 were pres-
ent in both alleles of all MMR-deﬁcient cell lines tested.
HCT116 displayed a bi-allelic mutation consisting of loss
of 2 bp in one allele and loss of 1 bp in the other allele. In
DLD1, the major form of MRE11 corresponded to the loss of 2
bp, but the presence of a residual wild-type allele could be
detected. LoVo showed a homozygous mutation consisting of
1 bp deletion. LoVo and HCT116 showed heterozygous muta-
tions in RAD50 and/or BLM, all consisting in the deletion of
1 bp in the A9 tracts.
DISCUSSION
The aim of our study is to investigate whether a defect in DSB
repair by NHEJ could account for the hypersensitivity of
MMR-deﬁcient CRC cell lines to the cytotoxic effects of
topoisomerase inhibitors. We have evaluated the efﬁciency
and the accuracy of DSB repair in cell lines with various
MMR defects, using an in vivo repair assay using plasmids
linearized with restriction enzymes to generate cohesive or
non-complementary ends. In this study, we have observed
signiﬁcant differences in the DSB repair efﬁciency among
the cell lines tested, but the ability to perform efﬁcient end-
joining did not require a functional MMR system. As already
reported in other studies using similar assays, the efﬁciency of
repair of DSB with non-complementary ends was comparable
to that of substrates with complementary 30-PSS or 50-PSS
(20,21). Interestingly, we have observed that LoVo, as well
as HCT116, DLD1 and their MMR-complemented counter-
parts are exquisitely accurate in end-joining DSB with cohes-
ive ends, compared with the MMR-proﬁcient HT29 cell line
whose behavior was similar to that of various MMR-proﬁcient
cells, including CHO, normal human ﬁbroblasts and normal
human Epstein–Barr virus-transformed lymphoblastoid cell
lines (20–24). Our observations are further reminiscent of a
recent report performed with Mlh1-null mouse embryonic
ﬁbroblasts showing that Mlh1 does not inﬂuence the overall
efﬁciency of DSB repair, but modulates error-prone NHEJ
(25). The experimental system used in this study did not
explore error-free repair, but revealed that rearrangements
performed during NHEJ are less complex in Mlh1-deﬁcient
cells. This result is consistent with those obtained in our
experiments, where the deletions accompanying error-prone
events were signiﬁcantly shorter in the MMR-deﬁcient CRC
celllines thaninHT29. However,asunderlinedbythe authors,
because Mlh1 complementation of the Mlh1-null cells had not
been tested, the possibility that other genetic factors might
contribute to the differences observed in the NHEJ ﬁdelity
could not be formally excluded (25). In fact, our ﬁndings
showing that the MMR-complemented counterparts of
HCT116 and DLD1 behaved as their parental cells support
the hypothesis of the involvement of other determinants favor-
ing highly accurate DSB repair in these cells. The frameshift
mutations that accumulate in a number of genes harboring
repeated sequences, in MMR-deﬁcient cells, persist in their
MMR-complemented counterpart cells (26). This may explain
why the MMR-complemented cells behave like their parental
MMR-deﬁcient cells. The extreme accuracy in DSB repair by
NHEJ observed in the MMR-deﬁcient cells and their comple-
mented counterparts could be due to a decrease in the extent of
degradation of the transfected plasmid. Alternatively, distinct
mechanismsofNHEJwithvariableaccuracycontributetorepair
DSB with cohesive ends. It has been shown in an in vitro
study performed with extracts from human lymphoblastoid
cells that Ku70, Ku86, DNA–PKcs and ligase IV/XRCC4
are required to repair DSB with cohesive and blunt ends, but
antibodies against Ku and DNA–PKcs only partially inhibited
the repair process, suggesting that this type of DSB can be
repaired by an alternative pathway (27). Biochemical studies
performed with human cell extracts recently demonstrated that
the end-joining catalyzed by the ligase IV/XRCC4 complex
can in fact occur by a distinct pathway that depends on the
Mre11-Rad50-Nbs1 (M/R/N) complex and does not require
DNA–PKcs (27,28). The respective contributions of these two
NHEJ pathways, as well as their characteristics regarding the
efﬁciency and the ﬁdelity of repair have not been fully
assessed yet. If the preferred pathways were inﬂuenced by
the structure of DNA ends, it could explain why DNA–
PKcs mutants are impaired in rejoining radiation-induced
Table 1. Detection of frameshift mutations in mononucleotide repeats in DNA
damage signaling and repair genes
ATR BLM BRCA1 BRCA2 DNA–PKcs MRE11 RAD50
A10 A9 A8 A8 A10 T11 A9
HT29 wt wt wt wt wt wt wt
LoVo wt  1* wt wt wt  1  1/wt
HCT116 wt wt wt wt wt  2/ 1  1/wt
DLD1 wt wt wt wt wt  2* wt
The presence of frameshift mutations in mononucleotide repeated sequences
weresearchedintheMMR-proficientcelllineHT29andintheMMR-deficient
cell lines HCT116, DLD1 and LoVo. The type and the length of the repeatsare
specifiedforeachgeneanalyzed.WT,wildtypeindicatesthatnomutationcould
bedetectedin the mononucleotide tract. Foreach mutation,the numberofbase
pairinserted(+)ordeleted( )ismentioned.Asteriskindicatesthepresenceofa
residual wt allele.
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or plasmids with cohesive ends (11,29). In keeping, our results
showing that MMR-deﬁcient cell lines carry inactivating
mutations in RAD50 and/or MRE11 resulting in the under-
expression of the M/R/N complex (data not shown) may
explain why these cells are particularly accurate in repairing
DSB with complementary ends. First, M/R/N participates in
the exonucleolytic processing of DSB; in particular, it cleaves
the 30-PSS, such as those generated by ApaI, at the single- to
double-strandtransition(30,31).Second,inhumans,the NHEJ
pathway that depends on the M/R/N complex is an error-prone
mechanism compared with the efﬁcient and more accurate
pathway that involves the Ku complex to protect ends from
degradation prior to ligation (27).
Because MMR-deﬁcient CRC cells are hypersensitive to
topoisomerase inhibitors, we have evaluated the impact of
CPT treatment on the efﬁciency and the ﬁdelity of DSB repair.
We have observed that CPT treatment has a mild effect on the
repair efﬁciency of cohesive ends, but markedly decreases the
ability of all cell lines to repair DSB with non-complementary
ends, suggesting that repair of CPT-induced breaks may com-
pete with that of non-complementary termini. While DSB
caused by restriction enzymes possess complementary 4 bp
overhangs that can be directly aligned and ligated, substrates
with non-complementary ends, as well as CPT-induced DSB
that have non-ligatable 50OH/30P termini, need to be processed
to restore extremities competent for ligation. Several proteins,
including BLM and the M/R/N complex, have been implicated
in the processing of DSB with diverse structures. BLM, a 30–50
DNA helicase, has been reported to directly interact with
hMLH1, to assemble with Ku70/Ku80 complex and DNA–
PKcs near the site of DSB and to facilitate unwinding of DNA,
promoting the alignment of microhomology elements during
recombination (32–34). Interestingly, the sizes of the deletions
that occur during inaccurate DSB repair in the absence of
BLMaresigniﬁcantlysmallerthaninwild-typecells,similarly
to what we have observed in the hMLH1-deﬁcient cells. More-
over, the sequencing of error-prone events in the repair of
complementary ends further showed that in the MLH1-deﬁ-
cient cell line, microhomology-mediated end-joining was less
often used, as reported in BLM-deﬁcient cells (data not shown)
(33). Several observations suggest that the M/R/N complex
may also play a substantial role in the repair of DSB with non-
complementary termini, including CPT-induced DSB. Mre11
possesses a 30–50 exonuclease activity that is resumed when
short sequence homologies, typically 1–5 bp long, are found,
being then able to process to end-joining in the presence of
ligase Iorligase IV invitro (35).In Saccharomycescerevisiae,
the covalent complex formed by topoisomerase I and
DNA may be removed using the 30-endonuclease activity of
Mre11 (9,36). In addition, M/R/N foci are formed in cells
treated with CPT or etoposide, and Nbs1-deﬁcient cells are
highly sensitive to CPT (37–39). In that respect, it is note-
worthy that in addition to MRE11 and RAD50, BLM is also
targeted by the MSI-driven mutagenesis characteristic of
MMR-deﬁcient cells.
In conclusion, our study does not provide evidence for a
direct role of MMR components in the NHEJ-mediated repair
of DSB created by restriction enzymes. The MMR defect may
ratheractthroughtheaccumulationofanumberofMSI-driven
mutations that inactivate microsatellite-harboring genes with
key roles in damage signaling and/or repair of DNA damage,
notably CPT-induced DNA lesions.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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